11.79
Schlusskurs vom Vortag:
$11.98
Offen:
$11.9
24-Stunden-Volumen:
516.77K
Relative Volume:
0.60
Marktkapitalisierung:
$1.09B
Einnahmen:
$79.76M
Nettoeinkommen (Verlust:
$-120.53M
KGV:
-7.9181
EPS:
-1.489
Netto-Cashflow:
$3.75M
1W Leistung:
+0.17%
1M Leistung:
-12.73%
6M Leistung:
+54.93%
1J Leistung:
+54.12%
Meiragtx Holdings Plc Stock (MGTX) Company Profile
Firmenname
Meiragtx Holdings Plc
Sektor
Branche
Telefon
646-860-7985
Adresse
655 THIRD AVENUE, NEW YORK, NY
Compare MGTX vs VRTX, REGN, ARGX, RVMD, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
MGTX
Meiragtx Holdings Plc
|
11.79 | 1.14B | 79.76M | -120.53M | 3.75M | -1.489 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.10 | 121.57B | 12.34B | 4.34B | 3.71B | 16.87 |
|
REGN
Regeneron Pharmaceuticals Inc
|
762.63 | 69.95B | 14.92B | 4.42B | 3.79B | 41.04 |
|
ARGX
Argen X Se Adr
|
853.82 | 55.61B | 4.16B | 1.29B | 734.26M | 19.58 |
|
RVMD
Revolution Medicines Inc
|
187.53 | 39.98B | 742.00K | -1.37B | -1.07B | -7.0731 |
|
ONC
Beone Medicines Ltd Adr
|
316.01 | 33.81B | 5.76B | 514.49M | 1.10B | 4.4813 |
Meiragtx Holdings Plc Stock (MGTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-24 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-10-21 | Eingeleitet | Raymond James | Strong Buy |
| 2024-07-31 | Fortgesetzt | Chardan Capital Markets | Buy |
| 2020-10-23 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2020-09-15 | Fortgesetzt | BofA Securities | Buy |
| 2019-09-03 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-02-27 | Bestätigt | Chardan Capital Markets | Buy |
| 2018-07-03 | Eingeleitet | Barclays | Overweight |
| 2018-07-03 | Eingeleitet | BofA/Merrill | Buy |
Alle ansehen
Meiragtx Holdings Plc Aktie (MGTX) Neueste Nachrichten
MeiraGTx Holdings PLC (MGTX) Institutional Confidence - TradingKey
MeiraGTx Holdings PLC (MGTX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
MeiraGTx Holdings PLC (MGTX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
MeiraGTx Holdings PLC (MGTX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
MeiraGTx Holdings Market Sentiment - Benzinga España
TradingKey - TradingKey
MeiraGTx Holdings PLC (MGTX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
MGTX|MeiraGTx Holdings PLC|Price:12.300|Chg%:+0.530 - TradingKey
MeiraGTx Holdings Plc Revenue Breakdown – FWB:328 - TradingView
MGTX|MeiraGTx Holdings PLC|Price:11.770|Chg%:-0.330 - TradingKey
MeiraGTx CFO & COO Giroux sells $700,560 in shares - Investing.com UK
Form 144 MEIRAGTX HOLDINGS PLC For: 21 July By Investing.com - Investing.com Australia
Form 4 MeiraGTx Holdings PLC For: 21 July By Investing.com - Investing.com Nigeria
MeiraGTx CFO & COO Giroux sells $700,560 in shares By Investing.com - Investing.com Nigeria
Form 144 MEIRAGTX HOLDINGS PLC For: 21 July - Investing.com India
MeiraGTx CFO, COO Richard Giroux disposes of 56,000 shares for $700,560 - Bitget
MeiraGTx Holdings (NASDAQ: MGTX) CFO sells 56,000 shares in plan trade - Stock Titan
A Quick Look at Today's Ratings for MeiraGTx Holdings(MGTX.US), With a Forecast Between $19 to $30 - Moomoo
Penny Renee Fleck Net Worth (2026) - GuruFocus
MeiraGTx (MGTX) moves 5.5% higher: Will this strength last? - MSN
Wall Street Analysts See a 128.14% Upside in MeiraGTx (MGTX): Can the Stock Really Move This High? - Yahoo Finance
(MGTX) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
What This MeiraGTx Insider Sale Might Mean With Two Drug Filings Near - The Motley Fool
What This MeiraGTx Insider Sale Might Mean With Two Drug Filings Near - The Motley Fool
MeiraGTx Holdings (MGTX) Faces Selling Pressure, Testing Key Support LevelsPut Wall - dars.gov.et
MeiraGTx wins $400M investment from Oberland Capital - MSN
Cantor Fitzgerald Initiates MeiraGTx Holdings(MGTX.US) With Buy Rating, Announces Target Price $20 - Moomoo
Latham & Watkins Advises MeiraGTx on US$400 Million Strategic Investment by Oberland Capital - Latham & Watkins LLP
MeiraGTx (MGTX) Moves 5.5% Higher: Will This Strength Last? - Yahoo Finance
RBC Capital Adjusts MeiraGTx Price Target to $26 From $25, Maintains Outperform Speculative Risk Rating - Moomoo
H.C. Wainwright reiterates MeiraGTx stock rating on financing deal - Investing.com
MeiraGTx Secures Major Royalty Financing and Restructures Debt - The Globe and Mail
H.C. Wainwright reiterates MeiraGTx stock rating on financing deal By Investing.com - Investing.com South Africa
MeiraGTx Holdings (MGTX) Is Up 8.5% After Securing US$425M In New Funding Pathways – Has The Bull Case Changed? - simplywall.st
Form 4 MeiraGTx Holdings PLC For: 7 July - Investing.com India
Insider Sell: Stuart Naylor Sells 27,659 Shares of MeiraGTx Holdings PLC (MGTX) - GuruFocus
Form 4 MeiraGTx Holdings PLC For: 7 July By Investing.com - Investing.com Nigeria
Meiragtx chief scientific officer Naylor sells $409,470 in shares By Investing.com - Investing.com South Africa
Meiragtx chief scientific officer Naylor sells $409,470 in shares - Investing.com
MeiraGTx (MGTX) chief scientist sells 27,659 shares in pre-set 10b5-1 trades - Stock Titan
Exclusive BAC Article: MeiraGTx; AAV2-hAQP1 Q2 207 Data Xerostomia, BLA Filing 1st Half 2027, Bota-Vec Acquisition, Oberland Capital Cash Infusion, And Catalysts (NASDAQ:MGTX) - Seeking Alpha
Form 144 MeiraGTx Holdings plc For: 7 July By Investing.com - Investing.com Nigeria
MeiraGTx secures up to $400M from Oberland Capital By Investing.com - Investing.com South Africa
Meiragtx Holdings Plc shares rose 3.5% in pre-market trading. - Bitget
MGTX (NASDAQ): Proposed resale notice for 27,659 ordinary shares - Stock Titan
MeiraGTx Announces $400 million Strategic Investment by Oberland Capital to Support Development and Commercialization of AAV2-hAQP1 and Botaretigene Sparoparvovec - Investing News Network
MeiraGTx Secures $400 Million Investment from Oberland Capital to Accelerate Gene Therapy Commercialization - Minichart
Oberland pours up to $400M into MeiraGTx eye gene therapies - Yahoo Finance
Finanzdaten der Meiragtx Holdings Plc-Aktie (MGTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):